Dual interaction of agmatine with the rat α(2D)-adrenoceptor: Competitive antagonism and allosteric activation

British Journal of Pharmacology

Volumn 130, Issue 7, 2000, Pages 1706-1712

  Molderings, G J ^a   Menzel, S ^a   Kathmann, M ^a   Schlicker, E ^a   Gothert M ^b  

^a Inst F Pharmakol und Toxikologie   (Germany)

^b NONE

Author keywords

Agmatine; Allosteric site; Neurotransmission

Indexed keywords

AGMATINE; ALPHA 2D ADRENERGIC RECEPTOR; CLONIDINE; MOXONIDINE; NORADRENALIN; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; RAUWOLSCINE; TRITIUM;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MEMBRANE; CAVA VEIN; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ISOTOPE LABELING; MEMBRANE BINDING; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING;

EID: 0033853436     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703495     Document Type: Article

References (30)

1. BRICCA, G., DONTENWILL, M., LONIES, A., FELDMAN, J., BELCOURT, A. & BOUSQUET, P. (1989). The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. Eur. J. Pharmacol., 162, 1-9.
2. 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol. Pharmacol., 42, 1-5.
3. DE BLASI, A., O'REILLY, K. & MOTULSKY, H.J. (1989). Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol. Sci., 10, 227-229.
4. ERNSBERGER, P., GIULIANO, R., WILLETTE, R. N. & REIS, D.J. (1990). Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther., 253, 408-418.
5. FURCHGOTT, R.F. (1972). The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Handbook of experimental pharmacology. Catecholamines, vol XXXIII. ed. Blaschko H, Muscholl E. pp 283-335. Berlin, Heidelberg, New York: Springer.
6. GONZALEZ, C, REGUNATHAN, S., REIS, D.J. & ESTRADA, C. (1996). Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery. Br. J. Pharmacol., 119, 677-684.
7. GÖTHERT, M., SCHLICKER, E. & KOLLECKER, P. (1986). Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 332, 124-130.
8. GREENBERG, D.A., U'PRICHARD, D.C. & SNYDER, S.H. (1976). α-Noradrenergic receptor binding in mammalian brain: differential labelling of agonist and antagonist states. Life Sci., 19, 67-76.
9. 2-adrenoceptor and non-adrenoceptor imidazoline binding sites in the central nervous system. Br. J. Pharmacol., 109, 831-837.
10. 2 adrenergic receptors. Biochem. Pharmacol., 55, 1035-1043.
11. JURKIEWICZ, N.H., DO CARMO, L.G., HIRATA, H., DA COSTA SANTOS, W. & JURKIEWICZ, A. (1996). Functional properties of agmatine in rat vas deferens. Eur. J. Pharmacol., 307, 299-304.
12. LI, G., REGUNATHAN, S., BARROW, C.J., ESHRAGI, J., COOPER, R. & REIS, D.J. (1994). Agmatine: an endogenous clonidine-displacing substance in the brain. Science, 263, 966-969.
13. LORING, R.H. (1990). Agmatine acts as an antagonist of neuronal nicotinic receptors. Br. J. Pharmacol., 99, 207-211.
14. MOLDERINGS, G.J. (1997). Imidazoline receptors: basic knowledge, recent advances and future prospects for therapy and diagnosis. Drugs Future, 22, 757-772.
15. MOLDERINGS, G.J. & GÖTHERT, M. (1998). Presynaptic imidazoline receptors mediate inhibition of noradrenaline release from sympathetic nerves in rat blood vessels. Fundam. Clin. Pharmacol., 12, 388-397.
16. 3 subtype. Br. J. Pharmacol., 107, 352-355.
17. 2 binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 245-252.
18. OTAKE, K., RUGGIERO, D.A., WANG, H., MILNER, T.A. & REIS, D.J. (1998). Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res., 787, 1-14.
19. PILETZ, J.E., CHIKKALA, D.N. & ERNSBERGER, P. (1995). Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J. Pharmacol. Exp. Ther., 272, 581-587.
20. 2-adrenoceptors which modulate the firing rat of locus coeruleus neurones: an electrophysiological study in rat. Neuroscience Letters, 219, 103-106.
21. 2-adrenoceptor binding sites. Br. J. Pharmacol., 115, 689-695.
22. 2-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 10-16.
23. RAASCH, W, REGUNATHAN, S., LI, G. & REIS, D.J. (1995). Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci., 56, 2319-2330.
24. REGUNATHAN, S., FEINSTEIN, D.L., RAASCH, W. & REIS, D.J. (1996). Agmatine, the decarboxylated arginine is localized and synthesized in glial cells. Neuroreport, 6, 1897-1900.
25. REGUNATHAN, S. & REIS, D.J. (1996). Imidazoline receptors and their endogenous ligands. Annu. Rev. Pharmacol. Toxicol., 36, 511-544.
26. REIS, D.J. & REGUNATHAN, S. (1999). Agmatine: an endogenous ligand at imidazoline receptors is a novel neurotransmitter. Ann. New Yord Acad. Sci., 881, 65-80.
27. SASTRE, M., REGUNATHAN, S. & REIS, D.J. (1997). Uptake of agmatine into rat brain synaptosomes: possible role of cation channels. J. Neurochem., 69, 2421-2426.
28. 3 receptors. Neurochem. Int., 30, 73-83.
29. SZABO, B., URBAN, R., LIMBERGER, N. & STARKE, K. (1995). Cardiovascular effects of agmatine, a "clonidine-displacing substance", in conscious rabbits. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 268-273.
30. 2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 721-737.